MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROUFOGALIS, B. D.
Right arrow Articles by BEAUREGARD, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROUFOGALIS, B. D.
Right arrow Articles by BEAUREGARD, G.

Molecular Pharmacology, Vol 16, 189-195, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Role of Phospholipid (Cardiolipin) in the Modulation of Substrate and Inhibitor Interactions with Erythrocyte Acetylcholinesterase

BASIL D. ROUFOGALIS 1 and GUY BEAUREGARD 1

1 Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, B.C., V6T 1W5 Canada

The hydrolysis of acetylcholine by bovine erythrocyte acetylcholinesterase shows a break in the Arrhenius plot around 20°. Evidence is presented that the cardiolipin-associated enzyme is modulated by a temperature dependent conformational rearrangement of the active site induced by the binding of substrate and inhibitor to the enzyme. Neither carbamylation by o-nitrophenoldimethylcarbamate, decarbamylation nor the maximum velocity of acetylcholine hydrolysis (rate limited by deacetylation) showed a non-linear Arrhenius plot. The break the Arrhenius plot of acetylcholine hydrolysis appeared to parallel the nonlinear temperature dependence of Vmax/Km(app) which reflects the conformational rearrangement of the enzyme-substrate complex, the rate limiting step at subsaturating substrate concentrations. Treatment of the enzyme with high salt and phosphate, which abolishes the non-linear Arrhenius plot and permits the extraction of cardiolipin from the enzyme by chloroform/methanol, gave linear plots for the temperature dependence of Vmax/Km(app), indicating that in these conditions the rate-limiting step was altered or no longer modulated by temperature.

Above the transition temperature fluoride inhibited the cardiolipin-associated enzyme with a Hill slope greater than 1.0 (-n = 1.4), whereas below the transition temperature or in high salt and phosphate treated cardiolipin-dissociated enzyme the corresponding negative Hill slope was 1.0. The rate of irreversible inhibition at the active site by N,N'-dicyclohexylcarbodiimide also exhibited a break at around 20° , the large increase in the entropy of the reaction above this temperature being consistent with a conformational rearrangement of the active site.

Submitted on August 31, 1978
Accepted on January 30, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics